期刊文献+

散发性肌萎缩侧索硬化发病机制探讨:谷氨酸受体2Q/R部位RNA无效编辑和病理性TDP-43 被引量:1

Pathogenic mechanism of sporadic amyotrophic lateral sclerosis:From a perspective of inefficient GluA2 Q/R site-RNA editing and pathological TDP-43 in motor neurons
原文传递
导出
摘要 谷氨酸受体2(glutamate receptor A2,Glu A2)Q/R部位编辑率降低以及相关的RNA2的次黄嘌呤腺苷脱氨酶(adenosine deaminase acting on RNA2,ADAR2)的异常与病理性反式激活应答DNA结合蛋白43(transactivation response DNA-binding protein 43-k D,TDP-43)可同时发生在肌萎缩侧索硬化(amyotrophic lateral sclerosis,ALS)患者的运动神经元中,提示在ALS患者中,这些异常分子病变之间可能存在关联。条件性敲除ADAR2基因的ALS小鼠可表现为运动神经元的缓慢死亡。因为缺乏ADAR2可引起TDP-43的异常分布和聚集,引发神经细胞毒性,继而加速运动神经元变性及死亡。本文总结了Glu A2 Q/R部位RNA无效编辑的规律和病理性TDP-43在ALS发病中的作用,并讨论了可能影响ADAR2介导的RNA无效编辑的相关因素,以期为研发新的ALS治疗方法提供参考依据。 Inefficient glutamate receptor A2 (GluA2) Q/R site-RNA editing and related downregulation of adenosine deaminase acting on RNA2 (ADAR2) expression as well as pathological transactivation response DNA-binding protein 43-kD (TDP-43) can simultaneously occur in the same motor neurons in patients with amyotrophic lateral sclerosis (ALS), suggesting that there may be an association among these molecular abnormalities in ALS patients. The animal experiment has found that after knock-down ofADAR2 gene, the motor neurons of the rats showed a chronic death. The abnormal mislocalization and aggregation of TDP-43 fragments induced by ADAR2 difficiency results in nerve cell toxicity, then accelerating the degeneration and death of the motor neurons. This paper summarizes the role of inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in sporadic ALS, and discusses the possible influencing factors associated with inefficient RNA editing mediated by ADAR2, hoping to provide useful information to develop a novel therapeutic strategy for ALS.
出处 《神经病学与神经康复学杂志》 2016年第2期94-101,共8页 Journal of Neurology and Neurorehabilitation
基金 国家自然科学基金面上项目(编号81373619)
关键词 肌萎缩侧索硬化 谷氨酸受体 TDP-43 钙蛋白酶 发病机制 Amyotrophic lateral sclerosis Glutamate receptor TDP-43 Calpain Pathogenic mechanism
  • 相关文献

参考文献14

  • 1Mariely DeJesus-Hernandez,Ian R. Mackenzie,Bradley F. Boeve,Adam L. Boxer,Matt Baker,Nicola J. Rutherford,Alexandra M. Nicholson,NiCole A. Finch,Heather Flynn,Jennifer Adamson,Naomi Kouri,Aleksandra Wojtas,Pheth Sengdy,Ging-Yuek R. Hsiung,Anna Karydas,William W. Seeley,Keith A. Josephs,Giovanni Coppola,Daniel H. Geschwind,Zbigniew K. Wszolek,Howard Feldman,David S. Knopman,Ronald C. Petersen,Bruce L. Miller,Dennis W. Dickson,Kevin B. Boylan,Neill R. Graff-Radford,Rosa Rademakers.??Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS(J)Neuron . 2011 (2)
  • 2宋玉,王恒,潘卫东,刘云,徐萌.从运动神经元的TDP-43蛋白表达和ADAR2活性探讨肌萎缩侧索硬化症的发病机制[J].中国临床神经科学,2014,22(3):356-360. 被引量:6
  • 3暴洁,朱旭颖,蔡定芳.肌萎缩侧索硬化症的诊断与治疗进展[J].神经病学与神经康复学杂志,2013,10(4):205-209. 被引量:6
  • 4潘卫东,Shin Kwak,Akuto Hideyama,李俊燕,周里钢,王骏,蔡定芳.在未编辑的谷氨酸受体2Q/R部位促使RNA2的次黄嘌呤腺苷脱氨酶丢失引起运动神经元的缓慢死亡[J].中国临床神经科学,2013,21(1):1-11. 被引量:5
  • 5潘卫东,方正龙,刘云,郭伸.肌萎缩性侧索硬化症和兴奋性氨基酸[J].中国临床神经科学,2009,17(1):100-105. 被引量:7
  • 6Takenari Yamashita,Shin Kwak.??The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients(J)Brain Research . 2013
  • 7Takenari Yamashita,Hui Lin Chai,Sayaka Teramoto,Shoji Tsuji,Kuniko Shimazaki,Shin‐ichi Muramatsu,Shin Kwak.??Rescue of amyotrophic lateral sclerosis phenotype in a mouse model by intravenous AAV 9‐ ADAR 2 delivery to motor neurons(J)EMBO Mol Med . 2013 (11)
  • 8Christopher J. Donnelly,Ping-Wu Zhang,Jacqueline T. Pham,Aaron R. Haeusler,Nipun A. Mistry,Svetlana Vidensky,Elizabeth L. Daley,Erin M. Poth,Benjamin Hoover,Daniel M. Fines,Nicholas Maragakis,Pentti J. Tienari,Leonard Petrucelli,Bryan J. Traynor,Jiou Wang,Frank Rigo,C. Frank Bennett,Seth Blackshaw,Rita Sattler,Jeffrey D. Rothstein.??RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention(J)Neuron . 2013 (2)
  • 9Wojciech Garncarz,Aamira Tariq,Cornelia Handl,Oliver Pusch,Michael F. Jantsch.??A high-throughput screen to identify enhancers of ADAR-mediated RNA-editing(J)RNA Biology . 2013 (2)
  • 10Jeremy H. Herskowitz,Yair M. Gozal,Duc M. Duong,Eric B. Dammer,Marla Gearing,Keqiang Ye,James J. Lah,Junmin Peng,Allan I. Levey,Nicholas T. Seyfried.??Asparaginyl endopeptidase cleaves TDP‐43 in brain(J)Proteomics . 2012 (15-1)

二级参考文献112

  • 1潘卫东,方正龙,刘云,郭伸.肌萎缩性侧索硬化症和兴奋性氨基酸[J].中国临床神经科学,2009,17(1):100-105. 被引量:7
  • 2Yamashita T,Hideyama T,Teramoto S,et al.The abnormal processing of TDP-43 is not an upstream event of reduced ADAR2 activity in ALS motor neurons[J] .Neurosci Res,2012,73:153-160.
  • 3Kwak S,Hideyama T,Yamashita T,et al.AMPA receptor-mediated neuronal death in sporadic ALS[J] .Neuropathology,2010,30:182-188.
  • 4Melcher T,Maas S,Herb A,et al.A mammalian RNA editing enzyme[J] .Nature,1996,379:460-464.
  • 5Kawahara Y,Ito K,Sun H,et al.Glutamate receptors:RNA editing and death of motor neurons[J] .Nature,2004,427:801-801.
  • 6Kwak S,Kawahara Y.Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis[J] .J Mol Med,2005; 83:110-120.
  • 7Hideyama T,Yamashita T,Aizawa H,et al.Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons[J] .Neurobiol Dis,2012,45:1121-1128.
  • 8Buratti E,Brindisi A,Giombi M,et al.TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail:an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing[J] .J Biol Chem,2005,280:37572-37584.
  • 9Tan CF,Eguchi H,Tagawa A,et al.TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation[J] .Acta Neuropathol,2007,113:535-542.
  • 10Mackenzie IR,Bigio EH,Ince PG,et al.Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations[J] .Ann Neurol,2007,61:427-434.

共引文献17

同被引文献10

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部